Whether bronchial artery hypertrophy (and perhaps, development of hemoptysis) in BMPR2 mutated patients, may result from loss of function of the BMPR2 gene or simply reflects a greater disease severity remains to be determined. This evidence concerns the gene BMPR2 and Hemoptysis.